Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model

Jennifer A. Shuford, Mark S. Rouse, Kerryl E. Piper, James M. Steckelberg, Robin Patel

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Candida albicans biofilms complicate the treatment of infected implanted intravascular devices because of decreased antifungal susceptibility. In our investigation, 48 rabbits with experimental central venous catheter C. albicans infection were equally allocated to a control arm or to receive amphotericin B deoxycholate or caspofungin treatment while undergoing systemic and intraluminal lock therapy for 7 days. C. albicans was cultured from catheters from all control rabbits, from 3 that received amphotericin B, and from 0 that received caspofungin. Differences in colony counts were detected between the control and amphotericin (P<.001) and control and caspofungin (P<.001) arms. Caspofungin may be useful in the treatment of C. albicans biofilm-associated intravascular catheter infections, which warrants further study.

Original languageEnglish (US)
Pages (from-to)710-713
Number of pages4
JournalJournal of Infectious Diseases
Volume194
Issue number5
DOIs
StatePublished - Sep 1 2006

Fingerprint

caspofungin
Biofilms
Candida albicans
Catheters
Amphotericin B
Infection
Rabbits
Catheter-Related Infections
Central Venous Catheters
Equipment and Supplies
deoxycholate drug combination amphotericin B

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model. / Shuford, Jennifer A.; Rouse, Mark S.; Piper, Kerryl E.; Steckelberg, James M.; Patel, Robin.

In: Journal of Infectious Diseases, Vol. 194, No. 5, 01.09.2006, p. 710-713.

Research output: Contribution to journalArticle

@article{65f4ee6153db4f5cb0f310060010f7ed,
title = "Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model",
abstract = "Candida albicans biofilms complicate the treatment of infected implanted intravascular devices because of decreased antifungal susceptibility. In our investigation, 48 rabbits with experimental central venous catheter C. albicans infection were equally allocated to a control arm or to receive amphotericin B deoxycholate or caspofungin treatment while undergoing systemic and intraluminal lock therapy for 7 days. C. albicans was cultured from catheters from all control rabbits, from 3 that received amphotericin B, and from 0 that received caspofungin. Differences in colony counts were detected between the control and amphotericin (P<.001) and control and caspofungin (P<.001) arms. Caspofungin may be useful in the treatment of C. albicans biofilm-associated intravascular catheter infections, which warrants further study.",
author = "Shuford, {Jennifer A.} and Rouse, {Mark S.} and Piper, {Kerryl E.} and Steckelberg, {James M.} and Robin Patel",
year = "2006",
month = "9",
day = "1",
doi = "10.1086/506452",
language = "English (US)",
volume = "194",
pages = "710--713",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model

AU - Shuford, Jennifer A.

AU - Rouse, Mark S.

AU - Piper, Kerryl E.

AU - Steckelberg, James M.

AU - Patel, Robin

PY - 2006/9/1

Y1 - 2006/9/1

N2 - Candida albicans biofilms complicate the treatment of infected implanted intravascular devices because of decreased antifungal susceptibility. In our investigation, 48 rabbits with experimental central venous catheter C. albicans infection were equally allocated to a control arm or to receive amphotericin B deoxycholate or caspofungin treatment while undergoing systemic and intraluminal lock therapy for 7 days. C. albicans was cultured from catheters from all control rabbits, from 3 that received amphotericin B, and from 0 that received caspofungin. Differences in colony counts were detected between the control and amphotericin (P<.001) and control and caspofungin (P<.001) arms. Caspofungin may be useful in the treatment of C. albicans biofilm-associated intravascular catheter infections, which warrants further study.

AB - Candida albicans biofilms complicate the treatment of infected implanted intravascular devices because of decreased antifungal susceptibility. In our investigation, 48 rabbits with experimental central venous catheter C. albicans infection were equally allocated to a control arm or to receive amphotericin B deoxycholate or caspofungin treatment while undergoing systemic and intraluminal lock therapy for 7 days. C. albicans was cultured from catheters from all control rabbits, from 3 that received amphotericin B, and from 0 that received caspofungin. Differences in colony counts were detected between the control and amphotericin (P<.001) and control and caspofungin (P<.001) arms. Caspofungin may be useful in the treatment of C. albicans biofilm-associated intravascular catheter infections, which warrants further study.

UR - http://www.scopus.com/inward/record.url?scp=33748035709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748035709&partnerID=8YFLogxK

U2 - 10.1086/506452

DO - 10.1086/506452

M3 - Article

VL - 194

SP - 710

EP - 713

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 5

ER -